Newsroom

印尼雅加達--(BUSINESS WIRE)--(美國商業資訊)-- GE HealthCare (Nasdaq: GEHC)今日宣布，將根據印尼的「強化印尼醫療轉診網路」(SIHREN)計畫，提供300餘台電腦斷層掃描(CT)掃描儀，為超過2.8億印尼民眾提供公平、高品質的醫療服務。GE HealthCare將向所有38個省份（包括城市和偏遠地區）的公立醫院提供先進CT掃描儀，此為一份透過競爭性招標獲得的多年期合約的一部分。SIHREN計畫下的CT掃描儀採購是透過遵循伊斯蘭開發銀行採購條例的全競爭性國際招標流程完成。 SIHREN是印尼歷史上規模最大的醫療基礎建設投資專案，也是全球最大的多邊衛生專案之一。SIHREN旨在實現全國轉診系統現代化，擴大整個群島的診斷和治療服務可及性，重點關注非傳染性疾病(NCD)管理、孕產婦健康和疫情韌性建設。 透過推動轉診網路現代化、在所有省份擴大先進診斷服務可及性，此次合作讓公平、高品質的醫療服務更貼近每個社群——無論是城市還是偏遠地區。獲得能夠挽救生命的CT技術後，印尼全國民眾將能實現癌症、中風和心臟病等重症的早期發現和及時治療，協助挽救生命、改善...

印度尼西亚雅加达--(BUSINESS WIRE)--(美国商业资讯)-- GE HealthCare (Nasdaq: GEHC)今日宣布，将根据印度尼西亚的“强化印度尼西亚医疗转诊网络”(SIHREN)计划，提供300余台计算机断层扫描(CT)扫描仪，为超过2.8亿印度尼西亚民众提供公平、高质量的医疗服务。作为一份通过竞争性招标获得的多年期合同的一部分，GE HealthCare将向所有38个省份（包括城市和偏远地区）的公立医院提供先进CT扫描仪。SIHREN计划下的CT扫描仪采购，是通过遵循伊斯兰开发银行采购条例的全竞争性国际招标流程完成的。 SIHREN是印度尼西亚历史上规模最大的医疗基础设施投资项目，也是全球范围内最大的多边卫生项目之一。SIHREN旨在实现全国转诊系统现代化，扩大整个群岛的诊断和治疗服务可及性，重点关注非传染性疾病(NCD)管理、孕产妇健康和疫情韧性建设。 通过推动转诊网络现代化、在所有省份扩大先进诊断服务覆盖，此次合作让公平、高质量的医疗服务更贴近每个社区——无论是城市还是偏远地区。获得能够挽救生命的CT技术后，印度尼西亚全国民众将能实现癌症、中风和心脏病...

GIACARTA, Indonesia--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) ha annunciato oggi che fornirà più di 300 scanner CT (tomografia computerizzata) ai sensi del programma Strengthening Indonesia’s Health Referral Network (SIHREN) dell'Indonesia, per offrire cure eque e di alta qualità e più di 280 milioni di indonesiani. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore...

JAKARTA, Indonesien--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) gab heute bekannt, dass das Unternehmen im Rahmen des Programms „Strengthening Indonesia’s Health Referral Network“ (SIHREN) mehr als 300 CT-Scanner (Computertomographen) liefern wird, um für mehr als 280 Millionen Indonesier eine gleichberechtigte, qualitativ hochwertige Versorgung zu ermöglichen. GE HealthCare erhielt den Zuschlag für den mehrjährigen Vertrag in einem wettbewerblichen Vergabeverfahren und wird die fortschrittl...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Protectt.ai strengthened its Middle East & Africa presence with the appointment of Pushkar Singh as Country Head, MEA....

PARIS--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (“Valerio Therapeutics” or the “Company”) (Euronext Growth Paris: ALVIO) announces the appointment of Professor Eric Vivier as an Observer to its Board of Directors. His nomination as a Director will be submitted to shareholders at the Company’s next general meeting. Professor Eric Vivier works within Aix Marseille University and Assistance Publique-Hôpitaux de Marseille (AP-HM) and is also a professor at École Polytechnique (X). He...

PARIS--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (“Valerio Thérapeutiques” ou la “Société”) (Euronext Growth Paris : ALVIO), annonce la désignation du Professeur Eric Vivier en qualité d’Observateur du Conseil d’Administration dont la candidature en tant qu’Administrateur sera proposée aux actionnaires lors de la prochaine assemblée générale de la Société. Le Professeur Eric Vivier exerce au sein de l’Assistance Publique–Hôpitaux de Marseille (AP-HM) et est également Professeur à l...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Candriam (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name of...

MAIDENHEAD, England--(BUSINESS WIRE)--RWS (RWS.L), a global AI solutions company, has been granted a US patent for its Translation Decision Assistant – an advanced AI engine that transforms how organizations manage global content and translation at scale, enabling faster decisions and greater control across international teams. The patent describes methods to handle large volumes of multilingual content by automatically analyzing each project and recommending the smartest mix of linguists, mach...

NEW YORK--(BUSINESS WIRE)--  17th December 2025 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 16th December 2025 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Santander US Capital Markets LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest pri...